Over the follow-up period, disease progression was assessed using multiple criteria, namely development of HF in an outpatient setting, ODI, NT-proBNP progression, a composite of ODI and NT-proBNP progression, unplanned CV-related hospitalization, and unplanned HF hospitalization. The gene discussed is NPPB; the disease is hydrops fetalis.